http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs
1 online resource (xx, 275 pages) : illustrations.
Patently innovative provides a review of the importance of traditional patent law and emerging linkage regulations for pharmaceutical products on the global stage, with a focus on the linkage regime in Canada. The primary focus is on how innovation in the pharmaceutical sector can be strongly regulated and how government regulation can either stimulate or inhibit development of breakthrough products. Includes empirical research to relate innovation to drug lawA multidisciplinary approach is taken, including the intersection of IP (intellectual property) law, drug law and innovationDiscusses the impact of government regulation on firm innovation.
Background : drug approval, drug patenting, pharmaceutical linkage and public health policy -- Empirical analysis of drug approval -- Empirical analysis of pharmaceutical innovation and drug approval-drug patenting linkage -- Empirical analysis of drug patenting in multiple high-value cohorts -- ?Implications of empirical data : are pharmaceutical linkage regulations a success? -- Future directions : testable hypotheses and evolution toward global pharmaceutical linkage.
Includes bibliographical references and index.
Biohealthcare Publishing series on pharma, biotech and biosciences ; 13